{"id":"https://openalex.org/W2023965672","doi":"https://doi.org/10.3892/or.2013.2383","title":"Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers","display_name":"Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers","alternate_titles":[],"publication_year":2013,"publication_date":"2013-04-04","ids":{"openalex":"https://openalex.org/W2023965672","doi":"https://doi.org/10.3892/or.2013.2383","mag":"2023965672","pmid":"https://pubmed.ncbi.nlm.nih.gov/23563570"},"language":"en","primary_location":{"id":"doi:10.3892/or.2013.2383","doi":"https://doi.org/10.3892/or.2013.2383","is_oa":true,"landing_page_url":"https://doi.org/10.3892/or.2013.2383","pdf_url":"http://www.spandidos-publications.com/or/29/6/2415/download","source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2023965672"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"http://www.spandidos-publications.com/or/29/6/2415/download","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102974778","display_name":"Pavel Proch\u00e1zka","orcid":"https://orcid.org/0000-0001-7456-3322","observed_orcids":["https://orcid.org/0000-0001-7456-3322"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210097985","display_name":"University Hospital in Motol","ror":"https://ror.org/0125yxn03","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210097985","https://openalex.org/I4405269046"]}],"countries":["CZ"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"PAVEL PROCHAZKA","raw_affiliation_strings":["Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic. proch.pavel@gmail.com","Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic. proch.pavel@gmail.com","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"]},{"raw_affiliation_string":"Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019351423","display_name":"Jan Hrab\u011bta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210097985","display_name":"University Hospital in Motol","ror":"https://ror.org/0125yxn03","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210097985","https://openalex.org/I4405269046"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"JAN HRABETA","raw_affiliation_strings":["Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048410481","display_name":"Ale\u0161 V\u00edcha","orcid":"https://orcid.org/0000-0003-3075-5554","observed_orcids":["https://orcid.org/0000-0003-3075-5554"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210097985","display_name":"University Hospital in Motol","ror":"https://ror.org/0125yxn03","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210097985","https://openalex.org/I4405269046"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"ALES VICHA","raw_affiliation_strings":["Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060475257","display_name":"\u0160imon Cipro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210097985","display_name":"University Hospital in Motol","ror":"https://ror.org/0125yxn03","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210097985","https://openalex.org/I4405269046"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"SIMON CIPRO","raw_affiliation_strings":["Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067413772","display_name":"Eva Stejskalov\u00e1","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210097985","display_name":"University Hospital in Motol","ror":"https://ror.org/0125yxn03","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210097985","https://openalex.org/I4405269046"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"EVA STEJSKALOVA","raw_affiliation_strings":["Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039042429","display_name":"Zden\u011bk Musil","orcid":"https://orcid.org/0000-0001-9134-8851","observed_orcids":["https://orcid.org/0000-0001-9134-8851"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"ZDENEK MUSIL","raw_affiliation_strings":["Institute of Biology and Medical Genetics, Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, 12108, Prague 2, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Biology and Medical Genetics, Charles University in Prague, First Faculty of Medicine and General Teaching Hospital, 12108, Prague 2, Czech Republic","institution_ids":["https://openalex.org/I21250087"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004651940","display_name":"Pavel Vodi\u010dka","orcid":"https://orcid.org/0000-0003-2376-1243","observed_orcids":["https://orcid.org/0000-0003-2376-1243"]},"institutions":[{"id":"https://openalex.org/I202391551","display_name":"Czech Academy of Sciences","ror":"https://ror.org/053avzc18","country_code":"CZ","type":"government","lineage":["https://openalex.org/I202391551"]},{"id":"https://openalex.org/I4210133092","display_name":"Czech Academy of Sciences, Institute of Experimental Medicine","ror":"https://ror.org/03hjekm25","country_code":"CZ","type":"facility","lineage":["https://openalex.org/I202391551","https://openalex.org/I4210133092"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"PAVEL VODICKA","raw_affiliation_strings":["Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 14200 Prague 4, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Experimental Medicine, Academy of Sciences of the Czech Republic, 14200 Prague 4, Czech Republic","institution_ids":["https://openalex.org/I202391551","https://openalex.org/I4210133092"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013532796","display_name":"Tom\u00e1\u0161 Eckschlager","orcid":"https://orcid.org/0000-0002-7813-1049","observed_orcids":["https://orcid.org/0000-0002-7813-1049"]},"institutions":[{"id":"https://openalex.org/I21250087","display_name":"Charles University","ror":"https://ror.org/024d6js02","country_code":"CZ","type":"education","lineage":["https://openalex.org/I21250087"]},{"id":"https://openalex.org/I4210097985","display_name":"University Hospital in Motol","ror":"https://ror.org/0125yxn03","country_code":"CZ","type":"healthcare","lineage":["https://openalex.org/I4210097985","https://openalex.org/I4405269046"]}],"countries":["CZ"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"TOMAS ECKSCHLAGER","raw_affiliation_strings":["Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Paediatric Hematology and Oncology, Second Medical School, Charles University in Prague and University Hospital Motol, 15006 Prague, Czech Republic","institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5102974778"],"corresponding_institution_ids":["https://openalex.org/I21250087","https://openalex.org/I4210097985"],"apc_list":null,"apc_paid":null,"fwci":0.4448,"has_fulltext":true,"cited_by_count":10,"citation_normalized_percentile":{"value":0.61863782,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"29","issue":"6","first_page":"2415","last_page":"2421"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11173","display_name":"Neurofibromatosis and Schwannoma Cases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11213","display_name":"Genomic variations and chromosomal abnormalities","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/neuroblastoma","display_name":"neuroblastoma","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8190000057220459},{"id":"https://openalex.org/keywords/cisplatin-resistance","display_name":"cisplatin resistance","score":0.949999988079071},{"id":"https://openalex.org/keywords/mycn-amplification","display_name":"MYCN amplification","score":0.8510000109672546},{"id":"https://openalex.org/keywords/neuroblastoma-cell-lines","display_name":"neuroblastoma cell lines","score":0.8899999856948853},{"id":"https://openalex.org/keywords/chemotherapy-response","display_name":"chemotherapy response","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.9493218660354614},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.8176168203353882},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.6554669737815857},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6159973740577698},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5449347496032715},{"id":"https://openalex.org/C120821319","wikidata":"https://www.wikidata.org/wiki/Q1501491","display_name":"Copy-number variation","level":4,"score":0.5280640721321106},{"id":"https://openalex.org/C7602840","wikidata":"https://www.wikidata.org/wiki/Q746284","display_name":"Gene duplication","level":3,"score":0.4945935904979706},{"id":"https://openalex.org/C2777956278","wikidata":"https://www.wikidata.org/wiki/Q14906753","display_name":"N-Myc","level":5,"score":0.4668945074081421},{"id":"https://openalex.org/C2777542201","wikidata":"https://www.wikidata.org/wiki/Q1336182","display_name":"Fluorescence in situ hybridization","level":4,"score":0.4644802510738373},{"id":"https://openalex.org/C120599132","wikidata":"https://www.wikidata.org/wiki/Q602889","display_name":"Multiplex ligation-dependent probe amplification","level":4,"score":0.4559602737426758},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.44521716237068176},{"id":"https://openalex.org/C2781018059","wikidata":"https://www.wikidata.org/wiki/Q207609","display_name":"Oncogene","level":4,"score":0.4358804225921631},{"id":"https://openalex.org/C55548728","wikidata":"https://www.wikidata.org/wiki/Q1465102","display_name":"Gene dosage","level":4,"score":0.4241771697998047},{"id":"https://openalex.org/C150194340","wikidata":"https://www.wikidata.org/wiki/Q26972","display_name":"Gene expression","level":3,"score":0.41082990169525146},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.4014515280723572},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.362048864364624},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.2143934667110443},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1673075556755066},{"id":"https://openalex.org/C141231307","wikidata":"https://www.wikidata.org/wiki/Q7020","display_name":"Genome","level":3,"score":0.05842915177345276},{"id":"https://openalex.org/C36823959","wikidata":"https://www.wikidata.org/wiki/Q373027","display_name":"Exon","level":3,"score":0.0},{"id":"https://openalex.org/C30481170","wikidata":"https://www.wikidata.org/wiki/Q37748","display_name":"Chromosome","level":3,"score":0.0},{"id":"https://openalex.org/C2779102060","wikidata":"https://www.wikidata.org/wiki/Q1124606","display_name":"Ganglioneuroma","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000071447","descriptor_name":"N-Myc Proto-Oncogene Protein","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005784","descriptor_name":"Gene Amplification","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009447","descriptor_name":"Neuroblastoma","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009687","descriptor_name":"Nuclear Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015513","descriptor_name":"Oncogene Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D015513","descriptor_name":"Oncogene Proteins","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015870","descriptor_name":"Gene Expression","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018628","descriptor_name":"Gene Dosage","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020128","descriptor_name":"Inhibitory Concentration 50","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.3892/or.2013.2383","doi":"https://doi.org/10.3892/or.2013.2383","is_oa":true,"landing_page_url":"https://doi.org/10.3892/or.2013.2383","pdf_url":"http://www.spandidos-publications.com/or/29/6/2415/download","source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},{"id":"pmid:23563570","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23563570","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology reports","raw_type":"Journal Article"},{"id":"pmh:oai:asep.lib.cas.cz:CavUnEpca/0396156","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11104/0224024","pdf_url":null,"source":{"id":"https://openalex.org/S7407055266","display_name":"ASEP","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.3892/or.2013.2383","doi":"https://doi.org/10.3892/or.2013.2383","is_oa":true,"landing_page_url":"https://doi.org/10.3892/or.2013.2383","pdf_url":"http://www.spandidos-publications.com/or/29/6/2415/download","source":{"id":"https://openalex.org/S124357017","display_name":"Oncology Reports","issn_l":"1021-335X","issn":["1021-335X","1791-2431"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","medline","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320412","host_organization_name":"Spandidos Publishing","host_organization_lineage":["https://openalex.org/P4310320412"],"host_organization_lineage_names":["Spandidos Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncology Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3262486025","display_name":"Study of contribution of different DNA-damaging mechanisms to toxicity of cytostatics to human chemosensitive and chemoresistant neuroblastomas","funder_award_id":"GAP301/10/0356","funder_id":"https://openalex.org/F4320321006","funder_display_name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky"},{"id":"https://openalex.org/G6628815164","display_name":null,"funder_award_id":"00064203","funder_id":"https://openalex.org/F4320322482","funder_display_name":"Akademie V\u011bd \u010cesk\u00e9 Republiky"}],"funders":[{"id":"https://openalex.org/F4320321006","display_name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","ror":"https://ror.org/01pv73b02"},{"id":"https://openalex.org/F4320322482","display_name":"Akademie V\u011bd \u010cesk\u00e9 Republiky","ror":"https://ror.org/053avzc18"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2023965672.pdf","grobid_xml":"https://content.openalex.org/works/W2023965672.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W180695818","https://openalex.org/W190146143","https://openalex.org/W1512072225","https://openalex.org/W1538408369","https://openalex.org/W1594164755","https://openalex.org/W1595867557","https://openalex.org/W1783699960","https://openalex.org/W1899313383","https://openalex.org/W1974317126","https://openalex.org/W1977327767","https://openalex.org/W1978019690","https://openalex.org/W1984767861","https://openalex.org/W1986020614","https://openalex.org/W1998135863","https://openalex.org/W1999424147","https://openalex.org/W2002889430","https://openalex.org/W2021575927","https://openalex.org/W2025235262","https://openalex.org/W2026461006","https://openalex.org/W2029126296","https://openalex.org/W2033037904","https://openalex.org/W2033232071","https://openalex.org/W2035129407","https://openalex.org/W2048771192","https://openalex.org/W2052864542","https://openalex.org/W2057738343","https://openalex.org/W2067606868","https://openalex.org/W2069161814","https://openalex.org/W2082816650","https://openalex.org/W2084239992","https://openalex.org/W2099249565","https://openalex.org/W2102640596","https://openalex.org/W2126560854","https://openalex.org/W2137899544","https://openalex.org/W2138809862","https://openalex.org/W2142339100","https://openalex.org/W2150148604","https://openalex.org/W2151402305","https://openalex.org/W2159633294","https://openalex.org/W2326525648","https://openalex.org/W2327054845","https://openalex.org/W4211031423"],"related_works":["https://openalex.org/W7222803973","https://openalex.org/W1974767963","https://openalex.org/W3097973904","https://openalex.org/W1978019690","https://openalex.org/W2900887066","https://openalex.org/W3030953587","https://openalex.org/W2784888390","https://openalex.org/W2026461006","https://openalex.org/W4399124926","https://openalex.org/W2102042143"],"abstract_inverted_index":{"Neuroblastoma":[0],"is":[1,38,279],"a":[2,130,238],"tumor":[3],"accounting":[4],"for":[5],"approximately":[6],"10%":[7],"of":[8,14,34,147,150,155,174,191,202,218,253,273,277],"all":[9,15],"childhood":[10,16],"malignancies":[11],"and":[12,41,77,79,89,93,98,105,139,227,261],"50%":[13],"cancer-related":[17],"deaths.":[18],"MYCN":[19,35,49,60,86,117,133,144,151,175,192,224,229,242,259,268,278],"gene":[20,36,50,61,87,193],"copy":[21,51,90,243,264],"number":[22,52,91,149,173,190,265],"variation":[23],"represents":[24],"the":[25,55,148,158,172,200,251,262],"most":[26],"important":[27],"prognostic":[28],"factor":[29],"in":[30,69,101,132,157,171,199,215,223,231,256,267],"neuroblastoma.":[31],"Prognostic":[32],"significance":[33],"expression":[37,62,118,145,230],"more":[39],"complicated":[40],"may":[42,247,271],"depend":[43],"on":[44],"other":[45],"factors":[46],"such":[47],"as":[48,282],"status.":[53],"In":[54,135,160],"present":[56],"study,":[57],"we":[58,164],"assessed":[59],"using":[63,96],"real-time":[64],"RT-PCR":[65],"following":[66,119],"cisplatin":[67,156,178,186,209,254],"treatment":[68,120,187,210],"three":[70],"human":[71],"neuroblastoma":[72,125,162,233,269,283],"cell":[73],"lines":[74],"(UKF-NB-3,":[75],"UKF-NB-4":[76,113,138],"SK-N-AS)":[78],"their":[80],"cisplatin-resistant":[81,137,232],"counterparts.":[82],"We":[83,206],"also":[84],"examined":[85],"status":[88],"(gain":[92],"amplification)":[94],"variations":[95,266],"interphase":[97],"metaphase":[99],"fluorescent":[100],"situ":[102],"hybridization":[103],"(FISH)":[104],"multiplex":[106],"ligation-dependent":[107],"probe":[108],"amplification":[109],"(MLPA).":[110],"Only":[111],"cisplatin-sensitive":[112],"cells":[114,126,141,163,183,203,234,270],"exhibited":[115,142],"decreased":[116],"with":[121,258],"cisplatin.":[122],"Other":[123],"sensitive":[124],"did":[127,165],"not":[128,166,212,236],"exhibit":[129],"change":[131,170,222],"expression.":[134],"contrast,":[136],"SK-N-AS":[140,182],"increased":[143,189,228],"irrespective":[146],"copies":[152,176,194],"or":[153],"concentration":[154],"medium.":[159],"MYCN-amplified":[161],"observe":[167],"any":[168],"significant":[169],"after":[177],"treatment,":[179],"whereas":[180],"MYCN-non-amplified":[181],"revealed":[184],"during":[185],"an":[188],"caused":[195],"by":[196,204],"2p":[197],"gain":[198],"majority":[201],"FISH.":[205],"postulated":[207],"that":[208],"does":[211],"result":[213],"directly":[214],"altered":[216],"transcription":[217],"MYCN.":[219],"A":[220],"functional":[221],"mRNA":[225],"levels":[226],"do":[235],"have":[237],"clear":[239],"relationship":[240],"to":[241,250],"numbers.":[244],"These":[245],"findings":[246],"further":[248],"contribute":[249],"understanding":[252],"chemotherapy":[255],"connection":[257],"expression,":[260],"possible":[263],"be":[272],"importance":[274],"since":[275],"targeting":[276],"being":[280],"tested":[281],"therapy.":[284]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2023965672","counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
